T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LSI
1751
DELISTED
Life Storage, Inc.
LSI
| $855K | ﹤0.01% |
14,700
| – | – |
|
|
AXLL
1752
DELISTED
AXIALL CORP COM STK (DE)
AXLL
| $854K | ﹤0.01% |
20,100
| – | – |
|
1753
Emcor
EME
$36.7B
| $852K | ﹤0.01% |
19,160
-1,000
| -5% | -$43K |
|
1754
WaFd
WAFD
$2.81B
| $851K | ﹤0.01% |
38,410
-12,600
| -25% | -$270K |
|
|
EFII
1755
DELISTED
Electronics for Imaging
EFII
| $844K | ﹤0.01% |
19,715
+415
| +2% | +$18.1K |
|
1756
Associated Banc-Corp
ASB
$6.07B
| $843K | ﹤0.01% |
45,242
| – | – |
|
|
CSR
1757
Centerspace
CSR
$939M
| $839K | ﹤0.01% |
10,267
+860
| +9% | +$70.1K |
|
1758
Kennametal
KMT
$2.32B
| $834K | ﹤0.01% |
23,300
-4,200
| -15% | -$160K |
|
1759
Wendy's
WEN
$1.65B
| $833K | ﹤0.01% |
92,215
-9,000
| -9% | -$76K |
|
1760
Celldex Therapeutics
CLDX
$3.35B
| $831K | ﹤0.01% |
3,035
-429
| -12% | -$107K |
|
1761
Rithm Capital
RITM
$5.79B
| $817K | ﹤0.01% |
63,950
+15,500
| +32% | +$196K |
|
1762
DNOW Inc
DNOW
$2.95B
| $812K | ﹤0.01% |
31,551
-122,267
| -79% | -$3.34M |
|
|
CST
1763
DELISTED
CST Brands, Inc.
CST
| $812K | ﹤0.01% |
18,611
-1,700
| -8% | -$68.3K |
|
|
VR
1764
DELISTED
Validus Hold Ltd
VR
| $810K | ﹤0.01% |
19,500
-5,900
| -23% | -$238K |
|
1765
CDW
CDW
$17.8B
| $809K | ﹤0.01% |
23,000
+2,300
| +11% | +$74.4K |
|
|
VGR
1766
DELISTED
Vector Group Ltd.
VGR
| $806K | ﹤0.01% |
68,077
| – | – |
|
|
FMER
1767
DELISTED
FIRSTMERIT CORP
FMER
| $800K | ﹤0.01% |
42,376
-3,700
| -8% | -$66.5K |
|
|
AXON
1768
Axon Enterprise
AXON
$50B
| $799K | ﹤0.01% |
30,160
| – | – |
|
1769
Boyd Gaming
BYD
$6.05B
| $799K | ﹤0.01% |
62,500
-22,400
| -26% | -$252K |
|
|
VRNT
1770
DELISTED
Verint Systems
VRNT
| $798K | ﹤0.01% |
26,893
| – | – |
|
1771
Integer Holdings
ITGR
$4.25B
| $796K | ﹤0.01% |
17,717
+3,840
| +28% | +$168K |
|
1772
Hancock Whitney
HWC
$6.37B
| $794K | ﹤0.01% |
25,860
| – | – |
|
1773
Sunstone Hotel Investors
SHO
$2.02B
| $779K | ﹤0.01% |
47,174
| – | – |
|
|
RPAI
1774
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $779K | ﹤0.01% |
46,700
| – | – |
|
1775
Tidewater
TDW
$4.55B
| $777K | ﹤0.01% |
743
+99
| +15% | +$112K |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.